ACCESSION: MSBNK-SMB_Measured-HSA015P0182002
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 24
COMMENT: RAW_SPEC {'EL20_pos_1690': {'bp': 316259.0, 'sum': 767192.0}, 'EL17_pos_1689': {'bp': 308862.0, 'sum': 795938.0}, 'EL18_pos_1696': {'bp': 274481.0, 'sum': 666220.0}, 'EL04_pos_1703': {'bp': 269290.0, 'sum': 660488.0}, 'EL01_pos_1696': {'bp': 253874.0, 'sum': 636925.0}, 'EL13_pos_1697': {'bp': 253648.0, 'sum': 629117.0}, 'EL16_pos_1695': {'bp': 252838.0, 'sum': 673816.0}, 'EL21_pos_1690': {'bp': 237026.0, 'sum': 644398.0}, 'EL10_pos_1695': {'bp': 236829.0, 'sum': 613319.0}, 'EL02_pos_1696': {'bp': 232977.0, 'sum': 704209.0}, 'EL15_pos_1695': {'bp': 228449.0, 'sum': 632060.0}, 'EL23_pos_1695': {'bp': 225906.0, 'sum': 613469.0}, 'EL19_pos_1701': {'bp': 225884.0, 'sum': 696841.0}, 'EL06_pos_1696': {'bp': 220926.0, 'sum': 672986.0}, 'EL14_pos_1697': {'bp': 211640.0, 'sum': 607762.0}, 'EL22_pos_1701': {'bp': 208978.0, 'sum': 674737.0}, 'EL12_pos_1697': {'bp': 201876.0, 'sum': 617442.0}, 'EL05_pos_1696': {'bp': 198505.0, 'sum': 647217.0}, 'EL08_pos_1695': {'bp': 193149.0, 'sum': 586248.0}, 'EL09_pos_1696': {'bp': 188684.0, 'sum': 599671.0}, 'EL11_pos_1696': {'bp': 184256.0, 'sum': 550499.0}, 'EL24_pos_1702': {'bp': 184134.0, 'sum': 562572.0}, 'EL07_pos_1691': {'bp': 168574.0, 'sum': 539825.0}, 'EL03_pos_2194': {'bp': 160887.0, 'sum': 640303.0}}
COMMENT: RETENTION_TIME_STDEV 0.151
COMMENT: PRECURSOR_M/Z_RAW 182.129079
COMMENT: PRECURSOR_M/Z_STDEV 0.000057
COMMENT: PRECURSOR_IN_MS1 mz 182.128843; int 41.882; delta(ppm) 0.864629
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.309; C9H15N3O; [M+H]+; delta(ppm) 0.309185
COMMENT: PROPOSED_MF MS-FINDER 3.113; C9H15N3O; [M+H]+; delta(ppm) 0.304430
COMMENT: PROPOSED_MF SIRIUS5_Sirius 28.221; C9H15N3O; [M+H]+; delta(ppm) 0.304430
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C9H15N3O; [M+H]+; delta(ppm) 0.304430
COMMENT: PROPOSED_MF SIRIUS6_Sirius 38.000; C9H15N3O; [M+H]+; delta(ppm) 0.304430
COMMENT: PROPOSED_MF SIRIUS6_Sirius 36.265; C6H16FN3O2; [M+H]+; delta(ppm) -5.969411
COMMENT: PROPOSED_MF SIRIUS6_Sirius 24.550; C7H13N6; [M+H]+; delta(ppm) 7.676542
COMMENT: PROPOSED_MF SIRIUS6_Sirius 22.289; C5H18N4OP; [M+H]+; delta(ppm) -1.392736
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.863; C4H17N6S; [M+H]+; delta(ppm) -10.832975
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.149; C3H16N7P; [M+H]+; delta(ppm) 5.979352
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.268; C11H17O2; [M+H]+; delta(ppm) -7.067574
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.908; C9H15N3O; [M+H]+; delta(ppm) 0.304430
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.092; C6H16FN3O2; [M+H]+; delta(ppm) -5.969411
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.105; ZNXAJGZPUQOEDZ-UHFFFAOYSA-N; [M+H]+; CCN1CCC2=C(CC1)OC(=N2)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.054; NQCPECCCWDWTJJ-UHFFFAOYSA-N; [M+H]+; CCN(CC)C1=NC(=O)C=C(C)N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; PGZWFWGPWUBXAZ-QMMMGPOBSA-N; [M+H]+; CCN1CCCC1C(=O)NCC#N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; MGESDKOHGQHZFN-UHFFFAOYSA-N; [M+H]+; N=1C=C(C(=C(N)C1C)COC)CN
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; ZIJBPFPFSGVPTO-UHFFFAOYSA-N; [M+H]+; O=C1C=C(N=C(N)N1)CCC(C)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.143; NQCPECCCWDWTJJ-UHFFFAOYSA-N; [M+H]+; 2-diethylamino-6-methylpyrimidin-4(1H)-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.899; PGZWFWGPWUBXAZ-QMMMGPOBSA-N; [M+H]+; (2S)-N-(cyanomethyl)-1-ethylpyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.872; ZNXAJGZPUQOEDZ-UHFFFAOYSA-N; [M+H]+; 6-ethyl-4,5,7,8-tetrahydro-[1,3]oxazolo[4,5-d]azepin-2-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.857; ZIJBPFPFSGVPTO-UHFFFAOYSA-N; [M+H]+; 2-amino-6-(3-methylbutyl)-3,4-dihydropyrimidin-4-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.826; MGESDKOHGQHZFN-UHFFFAOYSA-N; [M+H]+; 5-(aminomethyl)-4-(methoxymethyl)-2-methylpyridin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; PGZWFWGPWUBXAZ-QMMMGPOBSA-N; [M+H]+; (2S)-N-(cyanomethyl)-1-ethylpyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.994; ZNXAJGZPUQOEDZ-UHFFFAOYSA-N; [M+H]+; 6-ethyl-4,5,7,8-tetrahydro-[1,3]oxazolo[4,5-d]azepin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.964; MGESDKOHGQHZFN-UHFFFAOYSA-N; [M+H]+; 5-(aminomethyl)-4-(methoxymethyl)-2-methylpyridin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.904; ZIJBPFPFSGVPTO-UHFFFAOYSA-N; [M+H]+; 2-amino-6-(3-methylbutyl)-3,4-dihydropyrimidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.741; NQCPECCCWDWTJJ-UHFFFAOYSA-N; [M+H]+; 2-diethylamino-6-methylpyrimidin-4(1H)-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.434; ZNXAJGZPUQOEDZ-UHFFFAOYSA-N; [M+H]+; 6-ethyl-4,5,7,8-tetrahydro-[1,3]oxazolo[4,5-d]azepin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.676; NQCPECCCWDWTJJ-UHFFFAOYSA-N; [M+H]+; 2-(diethylamino)-4-methyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.483; VYCNDBQWMCGZAA-UHFFFAOYSA-N; [M+H]+; 2-amino-5-butyl-4-methyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.433; VINYJNGGVYOFMO-UHFFFAOYSA-N; [M+H]+; 2-[2-(dimethylamino)ethoxy]pyridin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.253; HSCWDVRVHYGIFA-UHFFFAOYSA-N; [M+H]+; 5-amino-1-[2-(dimethylamino)ethyl]pyridin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.218; IVCVUYGTIKYXFG-UHFFFAOYSA-N; [M+H]+; 2-[4-(oxolan-3-yl)pyrazol-1-yl]ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.050; XXIODYOSZOJCLL-UHFFFAOYSA-N; [M+H]+; 3-ethyl-5-piperidin-3-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.987; RYNLBXYARMGYPC-UHFFFAOYSA-N; [M+H]+; 4-amino-5-butyl-2-methyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.987; DQENLXHRPLSILC-UHFFFAOYSA-N; [M+H]+; 4-amino-5-pentyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.965; ALMLRHBBDXINTB-UHFFFAOYSA-N; [M+H]+; 5-methyl-4-(piperazin-1-ylmethyl)-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.960; KDHIXBKIBCKZQU-UHFFFAOYSA-N; [M+H]+; 4-(1-methylimidazol-2-yl)piperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.951; WKTDGUSTKNDUEI-UHFFFAOYSA-N; [M+H]+; 5-propan-2-yl-3-pyrrolidin-2-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.945; GXYDRMDRTXLIHI-UHFFFAOYSA-N; [M+H]+; 5-(aminomethyl)-3,4-diethyl-1H-pyridazin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.943; RFHQJLOTULCXTL-IONNQARKSA-N; [M+H]+; [(2R,3S)-2-(2-methylpyrazol-3-yl)oxolan-3-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.940; MUWLMGYRXAWPAY-UHFFFAOYSA-N; [M+H]+; 3-(3-ethyl-1,2,4-oxadiazol-5-yl)cyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.930; YPJOOPMYFLEHFQ-UHFFFAOYSA-N; [M+H]+; [2-(1-methylpyrazol-4-yl)oxolan-2-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.926; VPIPHCYJMTYWDB-UHFFFAOYSA-N; [M+H]+; 3-methyl-1-(oxan-4-yl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.925; GMHNKGPHJQRSMQ-UHFFFAOYSA-N; [M+H]+; 5-methyl-1-(oxan-4-yl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.925; KIJUVFXYFIUKHM-UHFFFAOYSA-N; [M+H]+; 1-propyl-6,7-dihydro-4H-pyrano[3,4-d]imidazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.920; XPNWLCXGUBWJGX-UHFFFAOYSA-N; [M+H]+; 3-methyl-5-(4-methylpiperidin-4-yl)-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.913; CQTKVYHURMMRPR-UHFFFAOYSA-N; [M+H]+; 2-(2-pyrrolidin-2-ylpropyl)-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.913; QZKNQIWHWNZUPG-UHFFFAOYSA-N; [M+H]+; 2-methyl-2-(1-methylpyrazol-4-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.912; KBRISCUGMBXEQV-UHFFFAOYSA-N; [M+H]+; 4-(1-methylpyrazol-4-yl)piperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.911; HMELYHQGWKUPAH-UHFFFAOYSA-N; [M+H]+; 4-(2-methylpyrazol-3-yl)piperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.910; SGVSDXUFVJGQOJ-UHFFFAOYSA-N; [M+H]+; 1H-imidazol-2-yl(piperidin-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.909; UIVPKOOMHSYUNJ-UHFFFAOYSA-N; [M+H]+; 5-methyl-3-(piperidin-3-ylmethyl)-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.907; VNTQVHBPLVELRW-UHFFFAOYSA-N; [M+H]+; 2-(4-ethyl-1H-pyrazol-5-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.906; UHKUQSBZFWWHQL-UHFFFAOYSA-N; [M+H]+; 1-(2-amino-3-methylbutanoyl)azetidine-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.905; OOFRPEDNTOJVQY-UHFFFAOYSA-N; [M+H]+; 3-(3,5-dimethyl-1H-pyrazol-4-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.903; JTINBOGNUWUGGZ-UHFFFAOYSA-N; [M+H]+; 5-ethyl-3-piperidin-2-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.903; YONREVWIEOKSMK-UHFFFAOYSA-N; [M+H]+; 3-(azepan-2-yl)-5-methyl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.903; GQUXEPBUPCLZTC-UHFFFAOYSA-N; [M+H]+; 1-(2-methoxyethyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.901; BIOMFDHHARGJFB-UHFFFAOYSA-N; [M+H]+; 4-(3-methyl-1,2,4-oxadiazol-5-yl)cyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.896; QXNSDFXNTPPPMD-JGVFFNPUSA-N; [M+H]+; [(3S,4S)-4-(3-methylimidazol-4-yl)pyrrolidin-3-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.895; LUJBSCAJUSLCOU-UHFFFAOYSA-N; [M+H]+; 2-(1-methylpyrazol-4-yl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.895; FSYSYUOZJAUBEU-UHFFFAOYSA-N; [M+H]+; 2-(2-methylpyrazol-3-yl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.894; UROOQQFWCQYSFT-UHFFFAOYSA-N; [M+H]+; 2-(3-methylimidazol-4-yl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.893; IMEFHYRQGSBUQA-BDAKNGLRSA-N; [M+H]+; (2S,3R)-2-(1,5-dimethylpyrazol-4-yl)oxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.893; BZFBHNLGVKEULM-UHFFFAOYSA-N; [M+H]+; 2-(1-methylimidazol-2-yl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.879; HHJDARBBDLVPJM-UHFFFAOYSA-N; [M+H]+; 5-N-(2-methoxyethyl)-5-N-methylpyridine-2,5-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.863; SFUBOCVBYZCIFG-UHFFFAOYSA-N; [M+H]+; 5-methyl-2-(oxan-4-yl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.859; HCBVNRIFWSZMKU-UHFFFAOYSA-N; [M+H]+; 2-(4-amino-4,5,6,7-tetrahydroindazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.841; DWMYGDSJFUBVKQ-UHFFFAOYSA-N; [M+H]+; 1-methyl-5-(oxan-4-yl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.834; VWQGOQSMLIKZKR-UHFFFAOYSA-N; [M+H]+; 1-(5-methyl-1,2,4-oxadiazol-3-yl)cyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.832; FNHCEZVALREEJW-UHFFFAOYSA-N; [M+H]+; 2-methyl-5-(oxan-4-yl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.829; FNUWNALPTXNSAZ-UHFFFAOYSA-N; [M+H]+; 3-cyclopentyloxy-1-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.813; JRAVVMHGQVQNIQ-UHFFFAOYSA-N; [M+H]+; [2-(oxan-2-yl)pyrazol-3-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.790; VBBBTQSQJTVDDF-UHFFFAOYSA-N; [M+H]+; 4-methyl-5-(oxan-4-yl)-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.780; QSCAGDQZSRZPOH-UHFFFAOYSA-N; [M+H]+; 1-methyl-N-(oxan-4-yl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.763; HGZOYFLXLKNJHY-UHFFFAOYSA-N; [M+H]+; 3-[2-(2-oxopyrrolidin-1-yl)ethylamino]propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.714; GZIQHUCQRGBGBE-UHFFFAOYSA-N; [M+H]+; 1-[(4-aminopyridin-2-yl)amino]-2-methylpropan-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -189.031; RYNLBXYARMGYPC; [M+H]+; 6-Amino-5-butyl-2-methyl-4-pyrimidinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -207.588; NQCPECCCWDWTJJ; [M+H]+; 2-(diethylamino)-6-methylpyrimidin-4-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -210.015; GQUXEPBUPCLZTC; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -253.513; DQENLXHRPLSILC; [M+H]+; 6-Amino-5-pentyl-4-pyrimidinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -265.943; ZIJBPFPFSGVPTO; [M+H]+; 2-amino-6-(3-methylbutyl)-3H-pyrimidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -285.311; MGESDKOHGQHZFN; [M+H]+; Oprea1_123356
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -292.571; FNHCEZVALREEJW; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -306.401; GMHNKGPHJQRSMQ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -343.095; CQTKVYHURMMRPR; [M+H]+; 2-(2-pyrrolidin-2-ylpropyl)-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -444.694; ZNXAJGZPUQOEDZ; [M+H]+; Azepexol
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.080; RYNLBXYARMGYPC; [M+H]+; 6-Amino-5-butyl-2-methyl-4-pyrimidinol
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C9H16N3O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 2.764
MS$FOCUSED_ION: PRECURSOR_M/Z 182.128844
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-2900000000-65fbf664cc320cff854a
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  53.0388169 20.2350 53.039515 1.0370 6.34 0.0425 23 f{C4H5}/4.53ppm,p-C5H11N3O1
  55.0180833 19.5315 55.018791 1.1633 4.72 0.5534 23 f{C3H3O1}/4.40ppm,p-C6H13N3
  55.0544551 24.6801 55.055163 0.8537 9.15 -0.4513 24 f{C4H7}/4.15ppm,p-C5H9N3O1
  56.9424611 14.4044 56.943177 0.9483 5.27 -0.0138 23 ?
  57.0700857 27.2580 57.070802 0.8761 15.12 -0.1630 23 f{C4H9}/3.66ppm,p-C5H7N3O1
  58.0653089 19.6761 58.066029 1.1022 6.55 0.1000 24 f{C3H8N1}/3.16ppm,p-C6H8N2O1
  67.0543452 24.9721 67.055087 0.8650 9.93 -0.3348 24 f{C5H7}/1.77ppm,p-C4H9N3O1
  68.0495989 14.4228 68.050341 1.0434 2.23 0.7579 23 f{C4H6N1}/1.81ppm,p-C5H10N2O1
  69.0699880 15.3017 69.070731 0.8687 7.55 0.1579 20 f{C5H9}/1.61ppm,p-C4H7N3O1
  71.0492398 17.6630 71.049983 1.2245 5.44 -0.1532 23 f{C4H7O1}/1.39ppm,p-C5H9N3
  72.9372143 25.9520 72.937957 0.7404 5.77 0.0442 21 ?
  79.0542724 20.5907 79.055005 1.1385 8.53 0.0365 24 f{C6H7}/0.58ppm,p-C3H9N3O1
  80.9451032 78.9431 80.945830 0.7165 13.96 0.3870 24 ?
  81.0699361 33.4112 81.070662 0.8141 12.07 -0.2530 24 f{C6H9}/0.73ppm,p-C3H7N3O1
  83.0855839 13.6144 83.086303 1.0230 4.46 0.0883 21 f{C6H11}/0.69ppm,p-C3H5N3O1
  91.0543135 15.0976 91.054993 1.3618 9.66 -0.2211 19 f{C7H7}/0.95ppm,p-C2H9N3O1
  93.0698750 23.7723 93.070542 1.1067 8.39 -0.0978 23 f{C7H9}/-0.02ppm,p-C2H7N3O1
  94.0651521 15.2462 94.065812 1.0844 3.72 0.3922 21 f{C6H8N1}/0.28ppm,p-C3H8N2O1
  95.0490999 26.3730 95.049753 1.1257 10.69 -0.1601 23 f{C6H7O1}/-0.43ppm,p-C3H9N3
  95.0855006 35.7339 95.086153 0.9150 14.94 -0.2075 23 f{C7H11}/-0.28ppm,p-C2H5N3O1
  96.0444272 45.5143 96.045072 0.8329 4.86 0.7714 21 f{C5H6N1O1}/0.39ppm,p-C4H10N2
  97.0647166 13.5332 97.065354 1.5557 5.31 -0.1039 21 f{C6H9O1}/-0.77ppm,p-C3H7N3
  98.9556027 25.7497 98.956224 1.0611 7.36 -0.0682 23 ?
  105.0335150 106.6682 105.034079 0.6093 35.06 -0.2443 24 f{C7H5O1}/0.23ppm,p-C2H11N3
  107.0854950 18.8797 107.086037 1.2420 8.31 -0.0920 22 f{C8H11}/-0.30ppm,p-C1H5N3O1
  109.1012961 15.4783 109.101825 1.1732 6.11 -0.2982 19 f{C8H13}/1.09ppm,p-C1H3N3O1
  113.9637458 56.7091 113.964238 0.8336 15.25 -0.3073 23 ?
  114.0661412 15.6180 114.066632 1.3852 6.47 -0.2525 17 f{C4H8N3O1}/-0.41ppm,p-C5H8
  115.9700557 13.0382 115.970531 1.3624 4.17 -0.0439 19 ?
  116.9661857 124.2339 116.966652 0.7780 21.23 0.5757 24 ?
  121.1011032 19.9744 121.101532 1.3542 8.55 -0.1298 19 f{C9H13}/-0.61ppm,p-H3N3O1
  123.0440491 14.6160 123.044459 1.4954 5.56 0.0134 18 ?
  130.9818780 73.0470 130.982201 1.0001 13.58 0.1334 23 ?
  137.0709733 999.0000 137.071240 0.2991 0.00 1.0000 24 f{C7H9N2O1}/0.25ppm,p-C2H7N1
  138.0747015 77.1118 138.074970 1.0646 8.21 0.8096 24 ?
  139.9820717 15.5777 139.982346 1.3716 5.01 -0.2797 18 ?
  142.9819456 13.5887 142.982227 1.6645 4.71 -0.3561 19 ?
  155.9749638 14.4125 155.975281 1.5067 4.15 0.2271 20 ?
  156.9974586 18.5442 156.997779 1.0573 4.48 0.7403 21 ?
  158.9768729 43.9982 158.977198 0.6919 7.48 0.2075 20 ?
  166.9857892 16.0636 166.986138 1.1438 5.09 0.0025 17 ?
  170.9767995 18.3145 170.977159 1.6084 6.57 -0.2561 19 ?
  180.9373070 36.5520 180.937697 1.0280 8.46 0.3395 18 ?
  182.0092527 36.1521 182.009646 0.7967 12.19 -0.2797 18 ?
  182.9766296 18.0545 182.977025 1.4100 5.02 0.0421 20 ?
  183.0799050 17.6430 183.080301 1.4693 7.29 -0.4191 17 ?
PK$NUM_PEAK: 46
PK$PEAK: m/z int. rel.int.
  53.038817 20.23 20
  55.018083 19.53 19
  55.054455 24.68 24
  56.942461 14.40 14
  57.070086 27.26 27
  58.065309 19.68 19
  67.054345 24.97 24
  68.049599 14.42 14
  69.069988 15.30 15
  71.049240 17.66 17
  72.937214 25.95 25
  79.054272 20.59 20
  80.945103 78.94 78
  81.069936 33.41 33
  83.085584 13.61 13
  91.054313 15.10 15
  93.069875 23.77 23
  94.065152 15.25 15
  95.049100 26.37 26
  95.085501 35.73 35
  96.044427 45.51 45
  97.064717 13.53 13
  98.955603 25.75 25
  105.033515 106.67 106
  107.085495 18.88 18
  109.101296 15.48 15
  113.963746 56.71 56
  114.066141 15.62 15
  115.970056 13.04 13
  116.966186 124.23 124
  121.101103 19.97 19
  123.044049 14.62 14
  130.981878 73.05 73
  137.070973 999.00 999
  138.074702 77.11 77
  139.982072 15.58 15
  142.981946 13.59 13
  155.974964 14.41 14
  156.997459 18.54 18
  158.976873 44.00 43
  166.985789 16.06 16
  170.976799 18.31 18
  180.937307 36.55 36
  182.009253 36.15 36
  182.976630 18.05 18
  183.079905 17.64 17
//
